Creatine for Seniors: 3–5 g Daily, With Resistance Training
Informational summary of published trials and the ISSN position stand, not medical advice. If you have kidney disease, a reduced eGFR, or take drugs monitored by kidney function, talk to your clinician before starting.
Quick answer
Take 3–5 g of plain creatine monohydrate every day, skip the loading phase, and pair it with resistance training two or three days a week. That is the protocol the older-adult trials used, and the training is not optional: across 22 randomized trials, creatine added 1.37 kg more lean tissue than placebo in adults training in their late 50s to 70s, while creatine without training did nothing measurable for muscle or bone. The dose does not rise with age. What changes after 65 is why you take it: to slow the muscle loss that leads to weakness and falls, not to lift more at the gym.
Buy monohydrate, because it is the form sold at the studied dose. We read 1,200 creatine labels filed with the NIH: monohydrate labels sit at a median 5 g per serving, HCl at 2 g, buffered at 1.5 g. A premium form usually means a smaller dose at a higher price. See the census →
Already know the dose? See the best creatine picks ranked by cost per 5 g →
On this page
The dose table for older adults
| Situation | Dose | What the trials did | Notes |
|---|---|---|---|
| Maintenance, no loading | 3–5 g/day, every day | 3 g/day raised muscle creatine about 20% over 28 days, the same rise 20 g/day reached in 6 days (Hultman 1996, PMID 8828669) | The default over 60. Rest days included. |
| With resistance training | 0.1 g per kg body weight on training days, or 5 g/day | 0.1 g/kg, 3 days/week for 12 weeks, before or after the session with no difference (Candow 2014, PMID 24392772); 0.1 g/kg/day for 12 months in the bone trials | For 70 kg (154 lb) that is 7 g; for 90 kg (198 lb), 9 g. |
| Loading, optional | 20 g/day in 4 doses for 5–7 days, then 3–5 g/day | Muscle creatine up about 20% after 6 days at 20 g/day (Hultman 1996) | Same end point, a week faster. More stomach upset, early water weight, and a creatinine spike on any blood test that week. Not needed. |
| What the older-adult trials used | 3–5 g/day or 0.1 g/kg, with training 2–3 days/week | 22 trials, 721 participants, mean ages 57–70, 7–52 weeks (Chilibeck 2017, PMID 29138605) | A dose above this has no additional trial support. |
| How long | As long as you want the benefit | After stopping, muscle creatine drifted back to baseline within 30 days (Hultman 1996) | No cycling. No tolerance builds. |
The creatine dosage guide has the calculator for weight-based dosing and the loading maths for anyone who wants it.
Muscle and strength: creatine amplifies training, it does not replace it
Sarcopenia, the loss of muscle mass and strength with age, is the reason to consider creatine after 60. Muscle creatine stores fall with age, and older muscle responds to a full tank the way younger muscle does: more work per session, more adaptation from it.
The largest pooled analysis is Chilibeck’s 2017 meta-analysis of 22 randomized trials, 721 men and women with mean ages of 57 to 70, who trained two or three days a week for 7 to 52 weeks with creatine or placebo. Creatine produced a greater increase in lean tissue mass (mean difference 1.37 kg, 95% CI 0.97–1.76), in chest press strength (standardized mean difference 0.35) and in leg press strength (SMD 0.24) (PMID 29138605). The strength effects are small to moderate; the lean-mass effect is the one that matters for holding onto muscle through your 70s.
The earlier Devries and Phillips meta-analysis, 357 older adults averaging 64 years with about 12.6 weeks of training, found the same pattern: creatine plus training beat training alone on fat-free mass, chest and leg press one-rep max, and the 30-second chair stand, the strength you use to get out of a chair. It added nothing to knee extension or biceps curl strength and did not change fat mass (PMID 24576864). Both analyses call the trial pool limited and the effects modest.
Two results set the boundary. Chami and Candow gave older adults 0.3 g/kg/day or 0.1 g/kg/day of creatine for 10 days with no training and measured strength, endurance and balance: no effect at either dose (PMID 30820517). And the 2021 dosing-strategy meta-analysis by Forbes found that when the trials with a loading phase were excluded, creatine had no greater effect than placebo on chest or leg press strength, and that taking creatine only on training days was enough to increase both lean mass and strength (PMID 34199420). The summary: the muscle gain is reliable, the strength gain is real but smaller and less consistent, and neither shows up without the training.
Bone and falls: one hip result, no fracture data
Creatine’s bone story is mostly a muscle story: stronger muscle pulls harder on bone and makes a fall less likely. The direct evidence is thin and mixed.
Forbes’s 2018 meta-analysis pooled the five randomized trials of creatine plus resistance training lasting three months or more in adults over 50 or postmenopausal women, 193 participants in total. Creatine added nothing to bone mineral density at the whole body, hip, femoral neck or lumbar spine compared with training alone (PMID 29740583). Two of the five trials reported a benefit, and the longest is worth knowing. Chilibeck randomized 47 postmenopausal women to 0.1 g/kg/day of creatine or placebo during 12 months of supervised training: the creatine group lost 1.2% of femoral neck density against 3.9% on placebo, and gained width at the femoral shaft, a predictor of bending strength. Thirty-three women finished, and no other bone site differed (PMID 25386713). A later one-year trial in 70 adults averaging 58 years found creatine maintained bone area at the shin while placebo lost it, with no change at the forearm (Candow 2021, PMID 34107512).
The result that tells you what creatine does without training is Sales 2020: 200 postmenopausal women with osteopenia took 3 g/day of creatine or placebo for two years with no exercise program. Bone density at the spine, femoral neck and hip fell in both groups at the same rate; bone markers, microarchitecture, lean mass, muscle function, and the number of falls and fractures did not differ (PMID 31257405). The authors’ words: this refutes the idea that creatine alone builds muscle or bone over the long run.
On falls specifically, the 2019 Candow review argues that creatine, by increasing muscle mass and performance, has the potential to reduce fall risk (PMID 30978926). No trial has counted falls as a primary outcome, and the one that counted them as a secondary outcome (Sales 2020, without training) saw no difference. If fall prevention is the goal, the intervention with evidence is resistance and balance training; creatine is a plausible add-on, not a substitute. The vitamin D for seniors guide covers the other supplement in the falls conversation.
Memory: a small effect that reviews cannot agree on
The brain uses creatine for the same energy buffering muscle does, and brain creatine falls with age. The trial answers are modest.
Avgerinos’s 2018 systematic review found six randomized trials, 281 people in total, and concluded that short-term memory and reasoning may improve with creatine while results for long-term memory, attention, executive function, reaction time and mental fatigue were conflicting. Young adults showed no change; the authors suggested a potential benefit in older and stressed people (PMID 29704637). Prokopidis 2023 pooled eight randomized trials and found creatine improved memory measures overall (SMD 0.29, 95% CI 0.04–0.53), with a much larger effect in adults aged 66 to 76 (SMD 0.88) than in 11- to 31-year-olds, where the effect was zero. That older-adult subgroup carried 83% heterogeneity and a wide confidence interval (0.22–1.55), and the analysis drew a published letter challenging its statistics (PMID 35984306).
Xu 2024 is the largest pool: 16 randomized trials, 492 participants aged 21 to 76, all using monohydrate. Memory improved (SMD 0.31, 95% CI 0.18–0.44, rated moderate certainty), processing speed and attention improved with low certainty, and overall cognitive function and executive function did not change. Its subgroups favoured people aged 18 to 60 and people with a diagnosed disease, the reverse of the age pattern in the 2023 analysis (PMID 39070254). Three reviews, three pictures of who benefits. What they share: a small memory effect, nothing on overall cognition, no trial in dementia or mild cognitive impairment. On this evidence creatine is a muscle supplement that may carry a small cognitive bonus, not a memory supplement. The creatine for brain guide reads the individual trials.
Kidneys and your bloodwork: creatinine goes up, kidney function does not go down
This is the question that stops most older adults. Creatine is converted in the body to creatinine, the molecule the standard kidney blood test measures. Take creatine and serum creatinine rises a little, so a creatinine-based eGFR reads a little lower. That is arithmetic, not injury.
The randomized evidence: a 2026 meta-analysis of 19 randomized trials found creatine raised serum creatinine by 0.13 mg/dL (95% CI 0.07–0.18) with no difference in urea and no significant difference in eGFR (mean difference −5.2 mL/min/1.73 m², 95% CI −15.0 to 4.6, from the eight trials that reported it; a confidence interval that wide rules out a large decline but not a modest one, so this is reassurance with a caveat, not proof of no effect), and no difference between trials shorter or longer than a month (Tsiaras 2026, PMID 42035842). A 2025 meta-analysis of 12 trials found the same: a small, transient creatinine rise, most visible in the first week, and no change in GFR, which the authors attributed to metabolic turnover rather than kidney impairment (Naeini 2025, PMID 41199218). The 2019 meta-analysis reached the same conclusion: no renal damage at the amounts and durations studied (de Souza e Silva 2019, PMID 31375416). In the older-adult trials themselves, creatinine clearance stayed normal through 12 months (PMID 25386713) and kidney function did not change over 12 weeks (PMID 24392772).
The ISSN position stand puts the safety ceiling far above anything on this page: short- and long-term supplementation up to 30 g/day for five years is safe and well tolerated in healthy individuals and in patient populations from infants to the elderly (Kreider 2017, PMID 28615996). The 2023 narrative review by Longobardi adds the two caveats that matter for this page: a raised creatinine on creatine does not by itself indicate kidney dysfunction, and controlled trials in people with pre-existing kidney disease are still lacking (PMID 36986197).
What to do about your labs
Tell whoever orders your bloodwork that you take creatine, and list the dose with your medications. A creatinine-based eGFR can read a few points low while you take it; a cystatin C-based estimate does not depend on creatinine and is the cleaner number if the reading matters for a drug dose or a diagnosis. Do not load in the week before a blood draw. If your eGFR is already below 60, or you have chronic kidney disease, do not start on your own: that is the population the trials have not covered.
We read 1,200 labels: the studied dose is what monohydrate sells, and what the alternatives do not
Original research Every on-market creatine supplement label filed with the NIH Dietary Supplement Label Database (2,412 on the market, 1,200 read, 969 carrying a parseable creatine quantity, 788 with a daily direction), grouped by the chemical form the label names, with creatine per serving read from the Supplement Facts panel.
Monohydrate labels sit at a median 5 g per serving, and the 90th percentile is 5 g: the form barely varies, and it varies around the dose the older-adult trials used. The alternatives are sold smaller. Across 599 monohydrate labels, 110 HCl labels, 43 buffered labels and 39 magnesium chelate labels, the medians run 5 g, 2 g, 1.5 g and 0.6 g. Labels that name no form at all (171 of them) sit at 3 g. This is the finding that held in both halves of our read: Creatine monohydrate is dosed above the alternatives. A product that says HCl, buffered or chelate on the front is not a gentler version of the same dose; on the median label it is less than half the dose, sold on a solubility argument the evidence does not support (monohydrate vs HCl).
| Item | Value ( g) |
|---|---|
| Monohydrate (599) | 5 g |
| No form named (171) | 3 g |
| HCl (110) | 2 g |
| Buffered (43) | 1.5 g |
| Mg chelate (39) | 0.6 g |
Two more readings from the same labels. The median label directs 3.5 g a day against 3 g a serving, because some labels direct more than one serving; that gap also held in both halves (median dose as directed exceeds per-serving). And the top tenth of labels direct 12.8 g a day or more, loading territory printed on the tub as the everyday dose. If a label says four scoops, that is a loading protocol; take one scoop and ignore the rest. On delivery form, 790 of the labels we read are powders and 104 are capsules. Capsules suit people who dislike powder; check how many capsules it takes to reach 3–5 g, since one capsule cannot hold that much.
Method: 1,200 labels retrieved from the NIH Dietary Supplement Label Database (DSLD) v9 on 2026-08-30 for the term “creatine”; 2,412 are on the market; 969 declare creatine with a parseable quantity; 788 carry a daily direction. Per-serving figures are the Supplement Facts panel quantity; per-day figures multiply by the maximum daily servings the label directs. Chemical form is the form the label names. Every finding was recomputed in both halves of the read order: 2 of 4 held within tolerance and only those are claimed above. The 2 that did not (most of the market sells above the typical dose; a large share sells above the studied range) are deliberately not published as numbers. The figures on this page are open data (CC BY 4.0); cite this page. What it cannot tell you: which products sell most, whether the panel figure matches what is in the scoop, or anything about products not filed with the NIH.
How to take it after 60
Skip the loading phase. Hultman’s loading study, the one every protocol descends from, showed 3 g/day reaching the same 20% rise in muscle creatine over 28 days that 20 g/day reached in 6 (PMID 8828669). The month of patience costs nothing. Loading costs stomach upset, a few pounds of water, and a creatinine spike that can alarm a clinician who does not know you started.
Take it with the training, but timing does not matter. Before or after the session made no difference in older adults (PMID 24392772), and training days only was enough in the pooled analysis (PMID 34199420). Daily is simpler to remember; either works. Mix the powder in water, juice or a post-training protein shake and drink it within a few minutes, since dissolved creatine slowly degrades. Warm water dissolves it better than cold.
Drink normally. The idea that creatine dehydrates you or causes cramping is one the ISSN’s expert review examined and did not find evidence for (Antonio 2021, PMID 33557850). Creatine pulls water into muscle, which is the point, and ordinary fluid intake covers it. Older adults have a blunted thirst signal regardless; drink on a schedule.
Give it three months with the training before you judge it. The trials ran 7 to 52 weeks. A month of creatine without lifting anything is a fair test of the wrong intervention.
The product links below go to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.
The plain monohydrate to start with: Optimum Nutrition Micronized Creatine Monohydrate (60 servings) $0.27/day is 5 g of micronized monohydrate a scoop, banned-substance tested, and micronized powder dissolves more easily for anyone whose stomach objects to grit. The lowest cost per scoop we track is NOW Sports Creatine Monohydrate Powder (600g) $0.20/day, also plain monohydrate at 5 g. If you want Creapure purity from an NSF-listed brand, Thorne Creatine (Creapure, 90 servings) $0.49/day states NSF Certified for Sport on the label, though we could not confirm this SKU in the NSF registry. We do not currently track a capsule product; every pick in our catalog is a 5 g powder. Compare all of them in the best creatine guide.
Frequently asked questions
Is creatine safe for people over 65?
In healthy older adults, yes, on the evidence available. The ISSN position stand concludes that supplementation up to 30 g/day for five years is safe and well tolerated in healthy people from infants to the elderly, and the older-adult trials ran 3–5 g/day or 0.1 g/kg for up to a year with no kidney or liver signal. The evidence does not cover existing kidney disease; if your eGFR is already reduced, ask before starting.
Will creatine hurt my kidneys?
Controlled trials say no. A 2026 meta-analysis of 19 randomized trials found creatine raised serum creatinine by about 0.13 mg/dL with no change in eGFR or urea, and a 2025 meta-analysis found the same small, transient rise with no change in filtration rate. Creatine breaks down into creatinine, the molecule the blood test measures; the number moves, the kidneys do not. Trial evidence in people who already have kidney disease is missing, so that group should not self-start.
Do I need to load creatine?
No. Loading (20 g/day for 5–7 days) fills muscle stores in about a week; 3 g/day reaches the same level in about four weeks, and the end point is identical. For an older adult the loading week adds stomach upset, a few pounds of water and a temporary creatinine spike on any blood test that week, for no lasting gain. Start at 3–5 g/day and stay there.
Does creatine work without exercise?
For muscle and bone in older adults, not much. A 10-day trial of two creatine doses without training found no effect on strength or endurance, and a two-year trial of 3 g/day in 200 postmenopausal women without a training program found no effect on bone density, lean mass, falls or fractures. Every positive muscle result comes from creatine plus resistance training two to three days a week. The memory studies are the exception; they did not involve exercise.
Will I gain weight on creatine?
Usually a little, and it is water inside the muscle plus, with training, muscle itself. In the 22-trial meta-analysis, creatine plus resistance training added an average 1.37 kg more lean tissue than training alone, with no effect on fat mass in the earlier 2014 analysis. Skipping the loading phase keeps the early water shift small.
Can I take creatine with my medications?
No drug interaction has been demonstrated in the trials, and the ISSN expert review found no evidence that creatine causes dehydration, cramping or kidney harm at 3–5 g/day. The practical caution is about labs rather than pills: creatine nudges serum creatinine up, so tell whoever orders your bloodwork, and if you take a drug dosed or monitored by kidney function (metformin, some blood pressure drugs, daily NSAIDs), have that conversation before you start rather than after a surprising result.
Does creatine help memory in older adults?
Possibly; the effect is small and inconsistent across reviews. A 2023 meta-analysis found a memory benefit larger in adults aged 66–76 than in younger people, resting on few trials with high heterogeneity. A 2024 meta-analysis of 16 trials found a moderate-certainty memory benefit, no effect on overall cognition or executive function, and a larger effect in 18- to 60-year-olds, the opposite age pattern. No trial has tested creatine against dementia or mild cognitive impairment. Take it for your muscles; treat any memory effect as a bonus.
Related guides
- Creatine dosage guide: the weight-based calculator, loading maths, timing
- Best creatine overall: every verified monohydrate pick, ranked by cost per 5 g
- Monohydrate vs HCl: why the premium form is sold at a smaller dose
- Creatine for brain: the cognition trials, one by one
- Magnesium for seniors: the RDA, kidney margin and medication depletion after 65
- B12 for seniors: absorption falls with age even though the RDA does not rise
- Vitamin D for seniors: the 71+ RDA, testing, and the falls evidence
- The over-50 stack: what to combine and what to skip
Sources
- Chilibeck PD, et al. "Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis." Open Access J Sports Med. 2017. PMID: 29138605
- Devries MC, Phillips SM. "Creatine supplementation during resistance training in older adults-a meta-analysis." Med Sci Sports Exerc. 2014. PMID: 24576864
- Chami J, Candow DG. "Effect of Creatine Supplementation Dosing Strategies on Aging Muscle Performance." J Nutr Health Aging. 2019. PMID: 30820517
- Forbes SC, et al. "Meta-Analysis Examining the Importance of Creatine Ingestion Strategies on Lean Tissue Mass and Strength in Older Adults." Nutrients. 2021. PMID: 34199420
- Candow DG, et al. "Comparison of creatine supplementation before versus after supervised resistance training in healthy older adults." Res Sports Med. 2014. PMID: 24392772
- Forbes SC, et al. "Creatine Supplementation During Resistance Training Does Not Lead to Greater Bone Mineral Density in Older Humans: A Brief Meta-Analysis." Front Nutr. 2018. PMID: 29740583
- Chilibeck PD, et al. "Effects of Creatine and Resistance Training on Bone Health in Postmenopausal Women." Med Sci Sports Exerc. 2015. PMID: 25386713
- Candow DG, et al. "Efficacy of Creatine Supplementation and Resistance Training on Area and Density of Bone and Muscle in Older Adults." Med Sci Sports Exerc. 2021. PMID: 34107512
- Sales LP, et al. "Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial." J Gerontol A Biol Sci Med Sci. 2020. PMID: 31257405
- Candow DG, et al. "Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation." J Clin Med. 2019. PMID: 30978926
- Avgerinos KI, et al. "Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials." Exp Gerontol. 2018. PMID: 29704637
- Prokopidis K, et al. "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials." Nutr Rev. 2023. PMID: 35984306
- Xu C, et al. "The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis." Front Nutr. 2024. PMID: 39070254
- Tsiaras A, et al. "The effect of creatine supplementation on kidney function: a systematic review and meta-analysis of randomized controlled trials." J Ren Nutr. 2026. PMID: 42035842
- Naeini EK, et al. "Effect of creatine supplementation on kidney function: a systematic review and meta-analysis." BMC Nephrol. 2025. PMID: 41199218
- de Souza e Silva A, et al. "Effects of Creatine Supplementation on Renal Function: A Systematic Review and Meta-Analysis." J Ren Nutr. 2019. PMID: 31375416
- Longobardi I, et al. "Is It Time for a Requiem for Creatine Supplementation-Induced Kidney Failure? A Narrative Review." Nutrients. 2023. PMID: 36986197
- Kreider RB, et al. "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine." J Int Soc Sports Nutr. 2017. PMID: 28615996
- Antonio J, et al. "Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?" J Int Soc Sports Nutr. 2021. PMID: 33557850
- Hultman E, et al. "Muscle creatine loading in men." J Appl Physiol. 1996. PMID: 8828669
- NIH Office of Dietary Supplements. Dietary Supplement Label Database. dsld.od.nih.gov (creatine labels retrieved 2026-08-30).